Trial Profile

Dermal Safety Trial of Ztilido (Lidocaine patch 1.8%) for the Treatment of Postherpetic Neuralgia

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Dec 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lidocaine (Primary)
Indications Postherpetic neuralgia
Focus Adverse reactions

Most Recent Events

11 Aug 2014 This trial is expected to be completed by November 2014, and a New Drug Application is expected to be filed in the first quarter of 2015, according to a Scilex Pharmaceuticals media release.
11 Aug 2014 Status changed from recruiting to active, no longer recruiting, according to a Scilex Pharmaceuticals media release.
14 Jul 2014 Status changed from planning to recruiting according to the Scilex Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com